Richard van den Broek - 08 Apr 2025 Form 3 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard van den Broek
Issuer symbol
CRVS
Transactions as of
08 Apr 2025
Net transactions value
$0
Form type
3
Filing time
09 Apr 2025, 17:26:25 UTC
Previous filing
24 Jun 2024
Next filing
19 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRVS Common Stock 160,000 08 Apr 2025 See foonote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by HSMR Advisors, LLC, of which the Reporting Person is the sole owner.

Remarks:

Exhibit 24.1 - Power of Attorney